Growing evidence in aging and neurodegenerative diseases suggests that the polarization toward the neuroprotective status can be triggered by estrogens (132, 133), and this has been proven by estrogen replacement treatment through microglial ER subtypes, ERα and ERβ (134–136). This evidence concerns the gene ESR1 and neurodegenerative disease.